Online
Glenmark Pharma
BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 | Pharmaceuticals
| AGM/EGM | |||||
| Announcement Date |
Purpose | Date | Book Closure | Remarks | |
| From | To | ||||
| 03-09-2009 | AGM | 25-09-2009 | 14-09-2009 | 25-09-2009 | 40% Dividend |
| 02-09-2008 | AGM | 26-09-2008 | 22-09-2008 | 26-09-2008 | - |
| 01-09-2008 | EGM | 06-10-2008 | - | - | To create a mortgage / or charge over all the movable, immovable properties of the Company & to make investments upto a limit not exceeding Rs 4000 Crore. |
| 17-08-2007 | AGM | 20-09-2007 | 17-09-2007 | 20-09-2007 | - |
| 04-09-2006 | AGM | 29-09-2006 | 27-09-2006 | 29-09-2006 | - |
| 03-08-2005 | AGM | 27-09-2005 | 26-09-2005 | 27-09-2005 | - |
| 12-08-2004 | AGM | 24-09-2004 | 17-09-2004 | 24-09-2004 | - |
| 02-08-2003 | AGM | 26-09-2003 | 19-09-2003 | 26-09-2003 | - |
| 01-08-2002 | AGM | 27-09-2002 | 17-09-2002 | 27-09-2002 | Bookclsoure |
| 05-07-2002 | EGM | 29-07-2002 | - | - | Issue of 2500000 convertible debentures each to South Asia Regional Fund and CDC Financial Services (Mauritius) Ltd. on preferential basis. |
| 31-07-2001 | AGM | 28-09-2001 | 18-09-2001 | 28-09-2001 | Dividend 40% |
| 26-07-2000 | AGM | 22-09-2000 | 12-09-2000 | 22-09-2000 | - |
 | |||||
| Source : Religare Technova | |||||
| |||||
